Abstract
AbstractWe report the case of letrozole-induced radiation recall dermatitis (RRD) in a patient with a remote history of radiation therapy. There is only one previously known case of RRD triggered by letrozole in a patient with a recent (<3 month) history of radiation. Previously, only four other cases of aromatase-inhibitor-induced RRD have been reported. This case is significant for cancer care teams considering personalized treatments. In addition, improved long-term outcomes in cancer patients may lead to increases in and underdiagnoses of RRD. Likewise, RRD is patient specific, exacerbating health concerns, and can be difficult to recognize without proper awareness, documentation, and classification of triggering drugs. The authors hope to address these issues in this report.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Radiology Nuclear Medicine and imaging,Oncology
Reference23 articles.
1. D’Angio, G. J., Farber, S. & Maddock, C. L. Potentiation of x-ray effects by actinomycin D. Radiology 73, 175–177 (1959).
2. Ristic, B. Radiation recall dermatitis. Int J. Dermatol 43, 627–631 (2004).
3. Burris, H. A. 3rd & Hurtig, J. Radiation recall with anticancer agents. Oncologist 15, 1227–1237 (2010).
4. Melnyk, S. M., More, K. F. & Miles, E. F. Idiopathic radiation recall dermatitis developing nine months after cessation of Cisplatin therapy in treatment of squamous cell carcinoma of the tonsil. Case Rep. Oncol. Med 2012, 271801 (2012).
5. Barco, I. et al. Tamoxifen induced radiation recall dermatitis in a breast cancer patient. Breast J. 24, 662–663 (2018).
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献